B 376 (Imatinib Mesylate 100 mg)
Pill with imprint B 376 is Brown, Round and has been identified as Imatinib Mesylate 100 mg. It is supplied by Breckenridge Pharmaceutical, Inc..
Imatinib is used in the treatment of chronic myelogenous leukemia; acute lymphoblastic leukemia; chronic eosinophilic leukemia; dermatofibrosarcoma protuberans; gastrointestinal stromal tumor and belongs to the drug class BCR-ABL tyrosine kinase inhibitors. There is positive evidence of human fetal risk during pregnancy. Imatinib 100 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for B 376
Imatinib Mesylate
- Imprint
- B 376
- Strength
- 100 mg
- Color
- Brown
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Bcr-abl tyrosine kinase inhibitors
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Breckenridge Pharmaceutical, Inc.
- Manufacturer
- Stason Pharmaceuticals, Inc.
- National Drug Code (NDC)
- 51991-0376
Related Images for "B 376"
More about imatinib
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Pricing & Coupons
- En Español
- 39 Reviews
- Drug class: BCR-ABL tyrosine kinase inhibitors
Consumer resources
- Other brands
- Gleevec
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.